These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8728200)

  • 1. Impact of nutritional status on serum lipoprotein (a) concentration in patients undergoing continuous ambulatory peritoneal dialysis.
    Kang DH; Yoon KI; Lee SW; Kang SW; Choi KH; Lee HY; Han DS
    Perit Dial Int; 1996; 16 Suppl 1():S241-5. PubMed ID: 8728200
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
    Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional targets in peritoneal dialysis and markers of adequacy.
    Bosch JP; Watson J; Lew SQ
    Perit Dial Int; 1994; 14 Suppl 3():S105-9. PubMed ID: 7948257
    [No Abstract]   [Full Text] [Related]  

  • 4. The optimization of continuous ambulatory peritoneal dialysis.
    Oreopoulos DG
    Kidney Int; 1999 Mar; 55(3):1131-49. PubMed ID: 10027956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Residual renal function and nutritional status in patients on continuous ambulatory peritoneal dialysis].
    Jovanović N; Lausević M; Stojimirović B
    Med Pregl; 2005; 58(11-12):576-81. PubMed ID: 16673862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis.
    Amici G; Virga G; Da Rin G; Grandesso S; Vianello A; Gatti P; Bocci C
    Nephron; 1993; 65(3):469-71. PubMed ID: 8290003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is atherosclerosis accelerated by CAPD?
    Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O
    Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients.
    Dacko C; Holley JL
    Adv Perit Dial; 1996; 12():315-7. PubMed ID: 8865927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Aguilera A; Burgués S; Martínez-Ara J; Miguel JL; Gómez-Pan A; Selgas R
    Am J Kidney Dis; 1998 Sep; 32(3):454-63. PubMed ID: 9740162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival.
    Chung SH; Lindholm B; Lee HB
    Perit Dial Int; 2000; 20(1):19-26. PubMed ID: 10716579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis are not related to peritoneal losses of albumin.
    Montenegro J; Moina I; Saracho R; González O; Martínez I; Esteban M
    Nephron; 1997; 76(2):239-41. PubMed ID: 9200424
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between gastric emptying rate and nutritional status in patients treated with continuous ambulatory peritoneal dialysis.
    Stompór T; Hubalewska-Hola A; Staszczak A; Sulowicz W; Huszno B; Szybinski Z
    Perit Dial Int; 2002; 22(4):500-5. PubMed ID: 12322822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
    Anwar N; Bhatnagar D; Short CD; Mackness MI; Durrington PN; Prais H; Gokal R
    Nephrol Dial Transplant; 1993; 8(1):71-4. PubMed ID: 8381941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is rhGH anabolic in patients undergoing peritoneal dialysis?
    Stefanidis CJ
    Br J Clin Pract Suppl; 1996 Aug; 85():44-6. PubMed ID: 8995030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of acidosis on nutritional status in chronic peritoneal dialysis patients.
    Dumler F; Galan M
    Adv Perit Dial; 1996; 12():307-10. PubMed ID: 8865925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of peritoneal permeability and residual renal function on PD prescription.
    Harty J; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S147-52. PubMed ID: 8728182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional status in continuous ambulatory peritoneal dialysis patients.
    Sheil K; Mulligan S; Keogh JA
    Perit Dial Int; 1996; 16 Suppl 1():S461-3. PubMed ID: 8728245
    [No Abstract]   [Full Text] [Related]  

  • 20. Peritoneal membrane characteristics in patients on peritoneal dialysis.
    Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.